Drug Shortage Report for SANDOZ ATORVASTATIN

Last updated on 2024-07-09 History
Report ID 232468
Drug Identification Number 02324970
Brand name SANDOZ ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30FCT UD
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-07-08
Estimated end date 2024-07-26
Actual end date
Shortage status Actual shortage
Updated date 2024-07-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2024-07-09 English Compare
v2 2024-07-08 French Compare
v1 2024-07-08 English Compare

Showing 1 to 3 of 3